These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32785114)

  • 1. Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies.
    Antonello RM; Principe L; Maraolo AE; Viaggi V; Pol R; Fabbiani M; Montagnani F; Lovecchio A; Luzzati R; Di Bella S
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32785114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review.
    Antonello RM; Canetti D; Riccardi N
    J Antimicrob Chemother; 2022 Dec; 78(1):52-77. PubMed ID: 36227704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
    Candel FJ; Matesanz David M; Barberán J
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella.
    Perea EJ; Torres MA; Borobio MV
    Antimicrob Agents Chemother; 1978 May; 13(5):705-9. PubMed ID: 666297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.
    Lee YC; Chen PY; Wang JT; Chang SC
    BMC Pharmacol Toxicol; 2019 May; 20(1):25. PubMed ID: 31060599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
    Aktas G; Derbentli S
    J Glob Antimicrob Resist; 2017 Sep; 10():223-227. PubMed ID: 28735049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada.
    Zhanel GG; Zhanel MA; Karlowsky JA
    Can J Infect Dis Med Microbiol; 2018; 2018():8912039. PubMed ID: 30046362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa.
    Avery LM; Sutherland CA; Nicolau DP
    J Med Microbiol; 2019 Jun; 68(6):893-897. PubMed ID: 31050629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
    Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
    Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.
    Albiero J; Mazucheli J; Barros JPDR; Szczerepa MMDA; Nishiyama SAB; Carrara-Marroni FE; Sy S; Fidler M; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosfomycin in antimicrobial stewardship programs.
    Múñez Rubio E; Ramos Martínez A; Fernández Cruz A
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):62-66. PubMed ID: 31131594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant
    Leelasupasri S; Santimaleeworagun W; Jitwasinkul T
    J Pathog; 2018; 2018():3893492. PubMed ID: 29593912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
    García-de-la-Mària C; Gasch O; García-Gonzalez J; Soy D; Shaw E; Ambrosioni J; Almela M; Pericàs JM; Tellez A; Falces C; Hernandez-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Pujol M; Moreno A; Marco F; Miró JM
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo Antibacterial Activity of Linezolid Plus Fosfomycin Against
    Xie N; Jiang L; Chen M; Zhang G; Liu Y; Li J; Huang X
    Infect Drug Resist; 2021; 14():639-649. PubMed ID: 33658805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The revival of fosfomycin.
    Michalopoulos AS; Livaditis IG; Gougoutas V
    Int J Infect Dis; 2011 Nov; 15(11):e732-9. PubMed ID: 21945848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Linezolid and Fosfomycin in Catheter-Related Biofilm Infection Caused by Methicillin-Resistant Staphylococcus aureus.
    Chai D; Liu X; Wang R; Bai Y; Cai Y
    Biomed Res Int; 2016; 2016():6413982. PubMed ID: 27366751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
    Tong W; Wang R; Chai D; Li Z; Pei F
    Int J Antimicrob Agents; 2006 Nov; 28(5):454-6. PubMed ID: 16987639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.
    Di X; Wang R; Liu B; Zhang X; Ni W; Wang J; Liang B; Cai Y; Liu Y
    J Antibiot (Tokyo); 2015 Sep; 68(9):551-5. PubMed ID: 25805069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.